100 mg/kg cohort (n=20) | 200 mg/kg cohort (n=20) | |||
Before n (%) | After n (%) | Before n (%) | After n (%) | |
Any comorbidity | 5 (25) | 15 (75) | 2 (10) | 13 (65) |
Anaemia | 0 | 0 | 1 (5) | 0 |
Tachycardia | 1 (5) | 0 | 0 | 0 |
Patent ductus arteriosus | 1 (5) | 4 (20) | 0 | 2 (10) |
Bacterial sepsis | 1 (5) | 1 (5) | 0 | 0 |
Sepsis unspecified | 0 | 1 (5) | 0 | 2 (10) |
Low fibrinogen | 0 | 0 | 1 (5) | 0 |
Hyperglycaemia | 1 (5) | 2 (10) | 0 | 0 |
Hypoglycaemia | 1 (5) | 1 (5) | 1 (5) | 0 |
Hypoalbuminaemia | 0 | 0 | 1 (5) | 0 |
Hyponatraemia | 1 (5) | 8 (40) | 0 | 3 (15) |
Necrotising enterocolitis | 0 | 1 (5) | 0 | 1 (5) |
Hyperbilirubinaemia | 0 | 5 (25) | 0 | 10 (50) |
Intraventricular haemorrhage | 0 | 1 (5) | 0 | 0 |
Cerebral haemorrhage | 0 | 1 (5) | 0 | 0 |
Periventricular leukomalacia | 0 | 1 (5) | 0 | 0 |
Bronchopulmonary dysplasia | NA | 2 (10) | NA | 2 (10) |
Pneumothorax | 0 | 1 (5) | 0 | 1 (5) |
Pulmonary interstitial emphysema | 0 | 0 | 0 | 1 (5) |
NA, not applicable.